In vitro activity of a new antifungal triazole, D0870, against Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.

Ítems similars

• In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.
  per: Barchiesi, F, et al.
  Publicat: (1994)
• In vitro studies of a new antifungal triazole, D0870, against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts.
  per: Peng, T, et al.
  Publicat: (1993)
• In vitro antifungal susceptibility of Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus in Ethiopia
  per: Wabe, Nasir Tajure, et al.
  Publicat: (2012)
• Comparison of D0870, a new triazole antifungal agent, to fluconazole for inhibition of Candida albicans cytochrome P-450 by using in vitro assays.
  per: Venkateswarlu, K, et al.
  Publicat: (1996)
• Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard.
  per: Barchiesi, F, et al.
  Publicat: (1994)